Skip to main content
Caplight Logo









The Materia Company

The Materia Company

Private
MaltaHealthcare & Life Scienceshttps://www.themateriacompany.com/

Last Round

M&A

Oct 22, 2024

Total Funding Raised

$6.3M

Company Overview

The Materia Company operates in Healthcare & Life Sciences and is based in Malta. Its latest recorded funding round was a Seed round in June 2024.

The Materia Company is a pharmaceutical and medical device company that specializes in the research and development of innovative drug delivery platforms and therapeutic products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

The Materia Company Comparables

Compare The Materia Company with similar companies based on industry and business-model similarity.

The Materia Company comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nualtis
73%
Organigram Global Inc.
68%
Adare Pharma Solutions
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

The Materia Company Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AOct 22, 2024
SeedJun 20, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

The Materia Company Investors

Notable investors and investment history

The Materia Company investors
InvestorRounds
Pathlight VenturesSeed
AI2 IncubatorSeed
HaystackSeed
Thomson Reuters VenturesSeed
Spark CapitalSeed
AI HouseSeed

The Materia Company Filings

Explore SEC and related filing metadata, where available.

The Materia Company filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about The Materia Company's valuation, stock price, and market status.

Is The Materia Company a public or private company?

The Materia Company is a private company.

What is the current stock price of The Materia Company?

The Materia Company is a private company, so its shares have no public market price. Caplight tracks The Materia Company's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is The Materia Company worth (valuation)?

Valuation information for The Materia Company is not publicly available.

Can I buy The Materia Company stock?

The Materia Company shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was The Materia Company's last funding round?

The Materia Company's most recent funding round was M&A on October 22, 2024.

Who are the main investors in The Materia Company?

Key investors in The Materia Company include Spark Capital.

Will The Materia Company IPO soon?

No public IPO plans have been announced for The Materia Company.

How can I track The Materia Company secondary market activity?

Caplight tracks bids, offers, and trades in The Materia Company's shares on secondary markets.

Firmographic Details

HeadquartersMalta
Year Founded2016
Last FundingOct 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?